1 mg of retatrutide Triple G 20 (Retatrutyd) UPB Reta 10MG (Triple Agonist)
Description
Serving Size:1 capsule
This distinction underscores the importance of viewing GLP-1RAs as systemic immunometabolic modulators with secondary effects on thyroid autoimmunity, rather than as agents with direct thyroidal targets
Notably, 31% of patients on GLP-1 RAs became completely headache-free at 6 months, versus only 8% of those on usual care (this difference did not remain significant after adjusting for weight loss)
This personalization increases the likelihood of finding your effective dose quickly
Most of it is strength work, with a couple of days for conditioning and cardio
